+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients



High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients



Clinical Cancer Research 13(1): 132-138



Cervical cancer is now known to be caused by infection with an oncogenic type of the human papillomavirus (HPV). However, little is known about the continued role of HPV once cancer has been established. Here, we describe the quantitative relation between HPV DNA copy number and mRNA expression of the viral oncogenes (E6 and E7) and the prognostic value of both measures in cervical cancer patients. We studied the number of viral DNA copies and the level of HPV E6/E7 mRNA expression in 75 HPV 16-positive or HPV 18-positive International Federation of Gynecology and Obstetrics stage Ib and IIa cervical cancer patients. Measurements were done with quantitative PCR. DNA copy number analysis was done on pure tumor cell samples enriched with flow sorting. mRNA expression data were compensated for the percentage of tumor cells included. The number of viral DNA copies was not predictive of survival in cervical cancer patients. In contrast, high HPV E6/E7 mRNA expression was strongly related to an unfavorable prognosis (P = 0.006). In a multivariate Cox model for overall survival, including all known prognostic variables and stratified for HPV type, the level of E6/E7 mRNA expression was an independent prognostic indicator, second only to lymph node status. No correlation was observed between DNA copy number and the level of HPV E6/E7 mRNA expression, which reflects that not all DNA copies are equally transcriptionally active. Cervical cancer patients with high HPV E6/E7 oncogene mRNA expression have a worse survival independently from established prognostic factors.

(PDF emailed within 0-6 h: $19.90)

Accession: 049218645

Download citation: RISBibTeXText

PMID: 17200347

DOI: 10.1158/1078-0432.CCR-06-1568


Related references

Low initial human papillomavirus viral load may indicate worse prognosis in patients with cervical carcinoma treated with surgery. Journal of Gynecologic Oncology 26(2): 111-117, 2016

Expression of E6/E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade, viral load and p16INK4a. International Journal of Oncology 29(3): 705-711, 2006

Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. International Journal of Cancer 102(2): 152-158, 2002

Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene. Cancer Research 69(10): 4407-4414, 2009

Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition. Journal of Virology 74(8): 3752-3760, 2000

Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening. Journal of Lower Genital Tract Disease 21(1): 12-16, 2016

High grade cervical intraepithelial neoplasia and viral load of high-risk human papillomavirus: significant correlations in patients of 22 years old or younger. International Journal of Clinical and Experimental Pathology 2(2): 169-175, 2008

Prognostic significance of human papillomavirus viral load in correlation with different therapeutic modalities in cervical cancer patients. Pathology, Research and Practice 212(9): 804-810, 2017

Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study. Bmc Cancer 10: 650, 2011

Detection of human papillomavirus mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis. Proceedings of the American Association for Cancer Research Annual Meeting 42: 50, 2001

Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis. Journal of Clinical Oncology 17(5): 1391-1396, 1999

Human papillomavirus (HPV) typing in relation to ras oncogene mRNA expression in HPV-associated human squamous cervical neoplasia. International Journal of Biological Markers 20(4): 257-263, 2006

DETECTION OF E6-E7 MRNA OF HIGH RISK HUMAN PAPILLOMAVIRUS IN NEGATIVE LYMPH NODES IN PATIENTS WITH CERVICAL CANCER: A POSSIBLE EARLY BIOMARKER OF SUBCLINICAL METASTASIS: IGCS-0104 Cervical Cancer. International Journal of Gynecological Cancer 25 Suppl 1: 38-39, 2015

Over-expression of topoisomerase IIalpha is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment. International Journal of Gynecological Pathology 25(4): 383-392, 2006

Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer. Journal of Clinical Pathology 59(10): 1044-1051, 2006